What other ingredients are in apotex's ruxolitinib tablets?

What other ingredients are in Apotex's ruxolitinib tablets?

Apotex's ruxolitinib tablets contain the active ingredient ruxolitinib phosphate along with inactive ingredients that keep the tablet stable and help it lösen properly in the body. The company lists these als inactive ingredients in its prescribing information.

Are these ingredients listed in the official prescribing information?

Yes. Apotex submits its full composition details to the FDA, and the company publishes them in the prescribing information for its generic ruxolitinib. Users can read the full list in the official document.

What are the specific inactive ingredients?

The company does not publicly list every single inactive ingredient in marketing material. It instead provides the full composition in the official prescribing information. Users seeking the complete list can check the Apotex label or the FDA database.

How does this compare with the brand-name version?

The inactive ingredients in Apotex's generic ruxolitinib differ from those used in Incyte's Jakafi. Generics must match the active ingredient but may use different excipients. This can lead patients to ask about allergies or sensitivity to certain fillers.

Can patients be allergic to these ingredients?

Yes. Some patients may have known allergies or sensitivities to tablet fillers such as microcrystalline cellulose, lactose, or magnesium stearate. Patients who have concerns should discuss possible reactions with their prescribing physician before switching from the brand.

When does the Apotex patent expire?

No, Apotex does not hold the primary patent on ruxolitinib. The main composition-of-matter patent for ruxolitinib is held by Incyte. Apotex has received FDA approval for its generic version.

How long does Apotex ruxolitinib stay in the body?

Ruxolitinib has a half-life of approximately 3-5 hours. Apotex's generic meets the same specifications as any other approved ruxolitinib product.